Work

Mycophenolate Add-on Therapy Is Effective in Severe IgA Nephropathy

Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: IgA Nephropathy (IgAN) is the most common primary glomerulonephritis. There is limited evidence on the use of mycophenolate mofetil (MMF) in IgAN in non-Asian populations. This study evaluates the efficacy of MMF in IgAN. METHODS: Retrospective cohort study of patients with biopsy-confirmed IgAN between 2013 and 2024, with at least 6 months of follow-up. Patients were classified into three groups based on the treatment received in the first 6 months after diagnosis: (1) Supportive care, (2) Corticosteroids, (3) MMF add-on. Data were collected at baseline, 3, 6, 12, and 24 months. Changes in estimated glomerular filtration rate (eGFR), urinary protein-to-creatinine ratio (UPCR) and hematuria were assessed. The composite outcome included eGFR <15 mL/min/1.73 m2, kidney replacement therapy, the need for additional immunosuppressive therapy, kidney transplantation, or death assessed over a median follow-up of 43 months. Outcomes evaluated included eGFR below 15 ml/min/1.73m2, initiation of dialysis, transplantation, another immunosuppressant or death. RESULTS: Sixty-four patients were included: 19 MMF add-on, 14 Corticosteroids, and 31 Supportive care. Patients in the MMF add-on and corticosteroid groups had a more severe clinical profile compared to the Supportive care group. At 24 months, the MMF add-on and corticosteroids group showed a greater UPCR reduction compared to the Supportive care group (reduction of 57% p = 0.02 for both groups). In the MMF add-on group, hematuria reduction was significantly greater and renal function improved from the third month. CONCLUSIONS: Patients treated with MMF had similar outcomes to the supportive care group, despite having significantly more severe disease at baseline. These results suggest that MMF add-on could be a potential treatment for non-Asian patients with severe IgAN.
Source: Kidney360
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7236094411
FWCI:
Cites:
Cited by:
Related to: 10